natgillin/translations-raw huggingface dataset:
Combivir var effektivt til at nedsætte virusindholdet og få CD4-celletallet til at stige.
Combivir was effective at reducing viral loads and allowing CD4 cell counts to rise.
COMETRIQ 20 mg hårde kapsler Cabozantinib
COMETRIQ 20 mg hard capsules Cabozantinib
COMETRIQ 20 mg hårde kapsler COMETRIO 80 mg hårde kapsler
COMETRIQ 20 mg hard capsules COMETRIQ 80 mg hard capsules
COMETRIQ 20 mg hårde kapsler COMETRIQ 80 mg hårde kapsler Cabozantinib
COMETRIQ 20 mg hard capsules COMETRIQ 80 mg hard capsules Cabozantinib
COMETRIQ 20 mg hårde kapsler COMETRIQ 80 mg hårde kapsler Cabozantinib (S)-malat
COMETRIQ 20 mg hard capsules COMETRIQ 80 mg hard capsules Cabozantinib (S)-malate
COMETRIQ 20 mg kapsler er grå og har “XL184 20mg” trykt på den ene side.
COMETRIQ 20 mg capsules are grey and have “XL184 20mg” printed on one side.
COMETRIQ er indiceret til behandling af voksne patienter med progressiv, inoperabel, lokal fremskreden eller metastatisk thyroideacarcinom.
COMETRIQ is indicated for the treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma.
Cometriq har fået en "betinget godkendelse".
Cometriq has been given ‘conditional approval’.
COMMIT-forsøget, som var designet med 2x2 faktor, inkluderede 45.852 patienter, der var til rådighed inden for 24 timer efter indtrådte symptomer, som var mistænkt for at være MI og hvor EKG anomalier (dvs.
The 2x2 factorial design COMMIT trial included 45,852 patients presenting within 24 hours of the onset of the symptoms of suspected MI with supporting ECG abnormalities (i.e.
COMMIT-studiet, som var designet med 2x2 faktorer, inkluderede 45.852 patienter, der var til rådighed inden for 24 timer efter indtrådte symptomer, som var mistænkt for at være MI, og hvor ekg- anomalier (dvs.
The 2x2 factorial design COMMIT trial included 45,852 patients presenting within 24 hours of the onset of the symptoms of suspected MI with supporting ECG abnormalities (i.e.
common toxicity criteria (CTC, kriterium for gradering af bivirkninger) for ikke-hæmatologisk toksicitet ≤ grad 1 (undtagen for alopeci, kvalme og opkastning)
thrombocyte count ≥ 100 x 109/l common toxicity criteria (CTC) non-haematological toxicity ≤ Grade 1 (except for alopecia, nausea and vomiting).
common toxicity criteria (CTC, kriterium for gradering af bivirkninger) ikke-hæmatologisk toksicitet ≤ Grad 1 (undtagen alopeci, kvalme og opkastning)
thrombocyte count ≥ 100 x 109/l common toxicity criteria (CTC) non-haematological toxicity ≤ Grade 1 (except for alopecia, nausea and vomiting).
Common Toxicity Criteria (CTC, kriterium for gradering af bivirkninger) ikke-hæmatologisk toksicitet ≤ Grad 1 (undtagen for alopeci, kvalme og opkastning)
thrombocyte count ≥ 100 x 109/l common toxicity criteria (CTC) non-haematological toxicity ≤ Grade 1 (except for alopecia, nausea and vomiting).
Como la excreción renal es una de las vías de eliminación, hay que considerar la posibilidad de reducir la dosis de Siklos en pacientes con insuficiencia renal.
As renal excretion is a pathway of elimination, consideration should be given to decreasing the dose of Siklos in patients with renal impairment.
Como quiera que los trastornos clínicos derivados de las úlceras vasculares cutáneas notificadas en pacientes con enfermedades mieloproliferativas pueden ser graves, en caso de que aparezcan se suspenderá el tratamiento con hidroxicarbamida o se reducirá la dosis.
Due to potentially severe clinical outcomes for the cutaneous vasculitic ulcers reported in patients with myeloproliferative disease, hydroxycarbamide should be discontinued and/or its dose reduced if cutaneous vasculitic ulcerations develop.
Completers ++
Completers++
compliance muligvis påvirkes.
the compliance.
COMPOSICIÓN CUALITATIVA Y CUANTITATIVA
QUALITATIVE AND QUANTITATIVE COMPOSITION
Comprimido recubierto con película (comprimido).
Film-coated tablet (tablet).
Comprimidos recubiertos con película, redondos, de color blanquecino y grabado 100 en una cara.
Off-white round, film-coated tablet embossed 100 on one side.
COMT-hæmmere
COMT inhibitors
COMT-inhiberingen i de røde blodlegemer følger tæt plasmakoncentrationen, hvilket indikerer den reversible natur af COMT- hæmningen.
COMT inhibition in red blood cells closely follows the plasma concentrations of entacapone, thus clearly indicating the reversible nature of COMT inhibition.
Comtan 200 mg [på æsken]
Comtan 200 mg [folding box only]
Comtan 200 mg filmovertrukne tabletter Entacapon
Comtan 200 mg film-coated tablets Entacapone
Comtan 200 mg filmovertrukne tabletter er brun-orange, ovale tabletter mærket med ”Comtan” på den ene side.
Comtan 200 mg film-coated tablets are brownish-orange, oval tablets with “Comtan” engraved on one side.
Comtan anvendes sammen med levodopa (en kombination enten af levodopa og benserazid eller af levodopa og carbidopa), når patienterne får ’fluktuationer’ hen mod slutningen af perioden mellem to doser af medicinen.
Comtan is used together with levodopa (either a combination of levodopa and benserazide or a combination of levodopa and carbidopa) when the patient is having ‘fluctuations’ towards the end of the period between two doses of their medication.
Comtan anvendes til behandling af Parkinsons sygdom.
Comtan is used to treat patients with Parkinson’s disease.
Comtan har kun lindrende virkning på symptomerne fra Parkinsons sygdom, hvis det tages sammen med levodopa.
Comtan has no effect on relieving the symptoms of Parkinson’s disease unless taken with levodopa.
Comtan indeholder saccharose
Comtan contains sucrose
Comtan må ikke anvendes sammen med anden medicin, der tilhører gruppen af ’monoaminoxidasehæmmere’ (et antidepressionsmiddel).
Comtan should not be used together with other medicines that belong to the group ‘monoamine oxidase inhibitors’ (a type of antidepressant).
Comtan taget sammen med levodopa kan i sjældne tilfælde få dig til at føle dig meget døsig om dagen og medføre, at du pludseligt falder i søvn.
Comtan taken with levodopa may rarely make you feel very drowsy during the day, and cause you to suddenly fall asleep;
Comtan-tabletter indeholder entacapon og bruges sammen med levodopa til behandling af Parkinsons sygdom.
Comtan tablets contain entacapone and are used together with levodopa to treat Parkinson’s disease.
Comtan-tabletter indeholder sukkerstoffet saccharose.
Comtan tablets contain a sugar called sucrose.
comtess 200 mg [på æsken]
comtess 200 mg [folding box only]
Comtess 200 mg filmovertrukne tabletter
Comtess 200 mg film-coated tablets
Comtess 200 mg filmovertrukne tabletter entacapon
Comtess 200 mg film-coated tablets entacapone
Comtess 200 mg filmovertrukne tabletter er brun-orange, ovale tabletter mærket med ”COMT” på den ene side.
Comtess 200 mg film-coated tablets are brownish-orange, oval tablets with "COMT" engraved on one side.
Comtess anvendes sammen med levodopa (en kombination enten af levodopa og benserazid eller af levodopa og carbidopa), når patienterne får fluktuationer hen mod slutningen af perioden mellem to doser af medicinen.
Comtess is used together with levodopa (either a combination of levodopa and benserazide or a combination of levodopa and carbidopa) when the patient is having ‘fluctuations’ towards the end of the period between two doses of their medication.
Comtess anvendes til behandling af Parkinsons sygdom.
Comtess is used to treat patients with Parkinson’s disease.
Comtess anvendes, når disse fluktuationer ikke kan behandles alene med levodopa-standardkombinationen
Comtess is used when these fluctuations cannot be treated with the standard levodopa- containing combination alone.
Comtess har kun lindrende virkning på symptomerne fra Parkinsons sygdom, hvis det tages sammen med levodopa.
Comtess has no effect on relieving the symptoms of Parkinson’s disease unless taken with levodopa.
Comtess må ikke anvendes sammen med anden medicin, der tilhører gruppen af monoaminoxidasehæmmere (et antidepressionsmiddel).
Comtess should not be used together with other medicines that belong to the group ‘monoamine oxidase inhibitors’ (a type of antidepressant).
Comtess taget sammen med levodopa kan i sjældne tilfælde få dig til at føle dig meget døsig om dagen og medføre, at du pludseligt falder i søvn.
Comtess taken with levodopa may rarely make you feel very drowsy during the day, and cause you to suddenly fall asleep;
Comtess' sikkerhed og virkning hos børn under 18 år er ikke klarlagt.
The safety and efficacy of Comtess in children below age 18 have not been established.
Comtess-tabletter indeholder entacapon og bruges sammen med levodopa til behandling af Parkinsons sygdom.
Comtess tablets contain entacapone and are used together with levodopa to treat Parkinson’s disease.
Comunicación de efectos adversos
Reporting of side effects
conazol og phenytoin bør
voriconazole and phenytoin
CONBRIZA er kun blevet undersøgt hos kvinder, der er kommet i overgangsalderen og bør kun anvendes til dem..
CONBRIZA has only been studied in women who have reached menopause, and therefore is not recommended.
CONBRIZA indeholder det aktive stof bazedoxifen og er et lægemiddel, der hører til en gruppe af ikke-hormonale lægemidler benævnt selektive østrogenreceptormodulatorer (SERM).
CONBRIZA contains the active substance bazedoxifene, and is a medicine that belongs to a group of non-hormonal medicines called Selective Estrogen Receptor Modulators (SERMs).
CONBRIZA må kun bruges til behandling af kvinder, der har nået klimakteriet.
CONBRIZA is for use only by postmenopausal women.
CONBRIZA må kun bruges til behandling af postmenopausale kvinder.
CONBRIZA is only for use in postmenopausal women.
CONDICIONES ESPECIALES DE CONSERVACIÓN
SPECIAL STORAGE CONDITIONS
CONDICIONES GENERALES DE DISPENSACIÓN
GENERAL CLASSIFICATION FOR SUPPLY
CONDICIONES O RESTRICCIONES DE SUMINISTRO Y USO
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
CONDICIONES O RESTRICCIONES EN RELACIÓN CON LA UTILIZACIÓN SEGURA Y EFICAZ DEL MEDICAMENTO
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Conducción y uso de máquinas
Driving and using machines
Conestat alfa er en rekombinant form for human C1- inhibitor (rhC1INH).
Conestat alfa is a recombinant (not blood-derived) form of human C1 inhibitor (rhC1INH).
Conestat alfa udvindes af mælken fra kaniner, der har fået indsat gener, som gør dem i stand til at producere det menneskelige protein i deres mælk.
Conestat alfa is produced by ‘recombinant DNA technology’: it is extracted from the milk of rabbits that have been given genes that make them able to produce the human protein in their milk.
CONFIRM
0.128#
CONFIRM
0.46 (0.33, 0.63)
conivaptan – diuretika (bruges til at øge et lavt indhold af natrium i blodet) boceprevir, telaprevir – antiretroviralt lægemiddel (bruges til at behandle hepatitis C)
conivaptan – diuretic (used to increase low blood sodium levels) boceprevir, telaprevir – antiviral (used to treat Hepatitis C)
Conjunctivitis
Blepharitis
Conjunctivitis (herunder conjunctivitis, unormal tåresekretion)
Conjunctivitis (including conjunctivitis, lacrimal disorder)
conjunctivitis (øjenbetændelse)
conjunctivitis (inflammation of the conjuntiva of the eyes)
Conjunctivitis, makulopati, fotofobi
Conjunctivitis, maculopathy, photophobia
Conjunctivitis, øjenflåd, øjenlågsbetændelse, øjen- irritation, øjenhævelser, okulær hyperæmi, tåreflåd visuelt ubehag
Conjunctivitis, Eye discharge, Eyelid inflammation, Eye irritation, Eye swelling, Ocular hyperaemia, Tearing, Visual discomfort
Conjunktiva-blødning, øjenpruritus, keratitis, sløret syn, fotofobi
Conjunctival haemorrhage, eye pruritus, keratitis, vision blurred, photophobia
Conpisa,
Ind. Conpisa,
Conservación de Siklos
5 How to store Siklos
Conservación de siklos
How to store Siklos
Conservar a una temperatura inferior a 30 °C.
Store below 30 °C.
Conservar por debajo de 30°C.
Store below 30 °C.
Conservar por debajo de 30°C.
Store below 30°C.
Consilient Health Ltd., 5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Irland
Consilient Health Ltd., 5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland
Consistent met de bovenvermelde resultaten bleek, in een meta-analyse van 6 studies waarin 335 personen met clopidogrel in steady state werden behandeld, dat blootstelling aan de actieve metaboliet gedaald was met 28% bij mensen met een gemiddeld metabolisme en 72% bij mensen met een traag metabolisme, terwijl de bloedplaatjesaggregatieremming (5 μM ADP) daalde met verschillen in IPA van respectievelijk 5,9% en 21,4%, vergeleken met mensen met een snel metabolisme.
Consistent with the above results, in a meta-analysis including 6 studies of 335 clopidogrel-treated subjects at steady state, it was shown that active metabolite exposure was decreased by 28% for intermediate metabolisers, and 72% for poor metabolisers while platelet aggregation inhibition (5 μM ADP) was decreased with differences in IPA of 5.9% and 21.4%, respectively, when compared to extensive metabolisers.
Constella 290 mikrogram hårde kapsler
Constella 290 micrograms hard capsules
Constella 290 mikrogram hårde kapsler Linaclotid
Constella 290 micrograms hard capsules Linaclotide
Constella 290 mikrogram hårde kapsler.
Constella 290 micrograms hard capsules
Constella er ikke blevet undersøgt hos patienter, som har nedsat leverfunktion.
Constella has not been studied in patients who have hepatic impairment.
Constella er ikke blevet undersøgt hos patienter, som har nedsat nyrefunktion.
Constella has not been studied in patients who have renal impairment.
Constella fås i pakninger, der indeholder 10, 28, 60 eller 90 kapsler og i multipakninger med 112 kapsler, der består af 4 æsker, der hver indeholder 28 kapsler.
Constella is available in packs containing 10, 28, 60 or 90 capsules and in multipacks of 112 capsules comprising 4 cartons, each containing 28 capsules.
Constella kapsler er hvid til off white-orange uigennemsigtige kapsler mærket ”290” med gråt blæk.
Constella capsules are white to off-white-orange opaque hard capsules marked “290” with grey ink.
Constella linaclotid
Constella linaclotide
Constella vil ikke påvirke din evne til at føre motorkøretøj eller betjene maskiner
Constella will not affect your ability to drive or use machines
Constella virker lokalt i din tarm og hjælper dig til at føle mindre smerte, omindre oppustet og med at genoprette tarmens normale funktion.
Constella acts locally in your gut, helping you to feel less pain and less bloated, and to restore the normal functioning of your bowels.
Consulte a su médico o farmacéutico o enfermera antes de empezar a tomar Siklos
Talk to your doctor or pharmacist or nurse before taking Siklos
Consulte la sección 6.3 para ver la forma de guardar los comprimidos rotos sin usar.
For storage of unused broken tablets see section 6.3
CONT- 002 EVRA
CONT-002 EVRA
CONT- 003 COC*
CONT-003 COC
CONT- 003 EVRA
CONT-003 EVRA
CONT- 004
CONT-004
CONT- 004 EVRA
CONT-004 EVRA
Contacera 15 mg/ml oral suspension til hest
Contacera 15 mg/ml oral suspension for horses
Contacera 15 mg/ml oral suspension til hest Meloxicam
Contacera 15 mg/ml oral suspension for horses Meloxicam
Contacera 15 mg/ml oral suspension til heste
Contacera 15 mg/ml oral suspension for horses
Contacera 15 mg/ml oral suspension til heste Meloxicam
Contacera 15 mg/ml oral suspension for horses Meloxicam
Contacera 20 mg/ml injektionsvæske, opløsning til kvæg, svin og heste
Contacera 20 mg/ml solution for injection for cattle, pigs and horses
Contacera 20 mg/ml injektionsvæske, opløsning til kvæg, svin og heste Meloxicam
Contacera 20 mg/ml solution for injection for cattle, pigs and horses Meloxicam
Contacera er et generisk lægemiddel, hvilket betyder, at Contacera svarer til et "referenceveterinærlægemiddel", som allerede er godkendt i EU (Metacam).
Contacera is a ‘generic’, which means that Contacera is similar to a ‘reference veterinary medicine’ already authorised in the EU (Metacam).
Contacera indeholder meloxicam, som tilhører en lægemiddelgruppe, der kaldes ikke-steroide antiinflammatoriske lægemidler (NSAID'er).
Contacera contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Contenido del envase e información adicional Composición de Siklos
Contents of the pack and other information What Siklos contains
Contenido del prospecto:
What is in this leaflet
CONTENIDO EN PESO ,EN VOLUMEN O EN UNIDADES
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
Contra-indicaties
Contraindications
Contrada Fontana del Ceraso
Contrada Fontana del Ceraso 03012 Anagni (FR)
Contraindicaciones
Contraindications
Controlleren er fremstillet af hvid plast og har identifikationen ‘IONSYS’, et digitalt display, en lysrude og en doseringsknap.
The controller is made of white plastic with the identifier “IONSYS” and has a digital display, a light window, and a dosing button.
Controlleren er hvid med identifikationen ‘IONSYS®’ og har et digitalt display, en lysrude og en forsænket doseringsknap.
The controller is white with the identifier ‘IONSYS®’ and has a digital display, a light window, and a recessed dose activation button.
CONTROLOC Control bør ikke anvendes under amning.
Pantoprazole should not be used during breast-feeding.
CONTROLOC Control bør ikke anvendes under graviditet.
Pantoprazole should not be used during pregnancy.
CONTROLOC Control indeholder det aktive stof pantoprazol, som blokerer den ”pumpe”, der producerer mavesyre.
CONTROLOC Control contains the active substance pantoprazole, which blocks the ‘pump’ that produces stomach acid.
CONTROLOC Control kan reducere absorptionen af aktive stoffer, hvis biotilgængelighed er pH- afhængig (fx. ketoconazol).
CONTROLOC Control may reduce the absorption of active substances whose bioavailability is dependent on the gastric pH (e.g. ketoconazole).
Controloc Control svarer til et referencelægemiddel ved navn Controloc, som allerede er godkendt i Den Europæiske Union (EU).
Controloc Control is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Controloc.
Contusio, medicineringsfejl
Contusion, medication error
Convenia 80 mg/ml pulver og solvens til injektionsvæske, opløsning til hunde og katte
Convenia 80 mg/ml powder and solvent for solution for injection for dogs and cats
Convenia 80 mg/ml pulver og solvens til injektionsvæske, opløsning til hunde og katte Cefovecin
Convenia 80 mg/ml powder and solvent for solution for injection for dogs and cats Cefovecin
Convenia 80 mg/ml pulver til injektionsvæske, opløsning
Convenia 80 mg/ml powder for solution for injection for dogs and cats.
Convenia 80 mg/ml pulver til injektionsvæske, opløsning til hunde og katte
Convenia 80 mg/ml powder for solution for injection for dogs and cats
Convenia bør derfor ikke håndteres af personer, der er overfølsomme (allergiske) over for sådanne antibiotika, eller af personer der er blevet rådet til ikke at arbejde med dem.
Convenia should therefore not be handled by anyone who is hypersensitive (allergic) to such antibiotics, or by anyone who has been advised not to work with them.
Convenia har fordelen ved en lang virkningsvarighed.
Convenia has the benefit of a long duration of activity.
Convulsio: indsnævret SMQ “kramper”
Convulsion: narrow SMQ “Convulsions”
Coolock Dublin 17 Irland
Coolock Dublin 17 Ireland
Coombs
ystem
Coombs direkte test positiv, nedsat iltmætning
Coombs direct test positive, oxygen saturation decreased
Coombs’ direkte test positiv (Coombs’ test positiv), nedsat hæmoglobin (herunder nedsat hæmatokrit, nedsat haptoglobin), forhøjet alaninaminotransferase, forhøjet blodlaktatdehydrogenase, forhøjet aspartataminotransferase
Coombs` direct test positive (Coombs` test positive), decreased haemoglobin (including decreased haematocrit, decreased haptoglobin), increased alanine aminotransferase, increased blood lactate dehydrogenase, increased aspartate aminotransferase
Coombs’ test positiv, nedsat hæmoglobin (herunder nedsat hæmatokrit, nedsat haptoglobin), forhøjet alaninaminotransferase, forhøjet blodlaktatdehydrogenase, forhøjet aspartataminotransferase).
Coombs’ test positive, decreased haemoglobin (including decreased haematocrit, decreased haptoglobin), increased alanine aminotransferase, increased blood lactate dehydrogenase, increased aspartate aminotransferase).
Cooperia curticei
T. vitrinus Cooperia curticei
Copalia 5 mg/80 mg tabletter er runde og mørkegule, præget med ”NVR” på den ene side og ”NV” på den anden side.
Copalia 5 mg/80 mg tablets are round and dark yellow with “NVR” on one side and “NV” on the other side.
Copalia HCT 10 mg/160 mg/12,5 mg filmovertrukne tabletter amlodipin/valsartan/hydrochlorthiazid
Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 10 mg/160 mg/25 mg filmovertrukne tabletter amlodipin/valsartan/hydrochlorthiazid
Copalia HCT 10 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Copalia HCT 10 mg/320 mg/25 mg filmovertrukne tabletter amlodipin/valsartan/hydrochlorthiazid
Copalia HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Copalia HCT 5 mg/160 mg/12,5 mg filmovertrukne tabletter amlodipin/valsartan/hydrochlorthiazid
Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Copalia HCT 5 mg/160 mg/12,5 mg filmovertrukne tabletter er hvide, ovale tabletter præget med ”NVR” på den ene side og ”VCL” på den anden side.
Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets are white, oval tablets with “NVR” on one side and “VCL” on the other side.
Copalia HCT 5 mg/160 mg/25 mg filmovertrukne tabletter amlodipin/valsartan/hydrochlorthiazid
Copalia HCT 5 mg/160 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiaziade
Copalia HCT er kontraindiceret til patienter med hyperkalcæmi og bør kun anvendes efter korrektion af præ- eksisterende hyperkalcæmi.
Copalia HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any pre-existing hypercalcaemia.
Copalia HCT frarådes i den tidlige periode af graviditeten og må ikke tages, når du er mere end måneder henne i graviditeten, fordi det kan forårsage alvorlig skade på dit barn, hvis det tages efter tredje graviditetsmåned.
Copalia HCT is not recommended in early pregnancy and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Copalia HCT skal anvendes med forsigtighed ved behandling af hypertension hos patienter med unilateral eller bilateral nyrearteriestenose eller stenose i en enkelt nyre, da blod-urea og serum- kreatinin kan stige hos disse patienter.
Copalia HCT should be used with caution to treat hypertension in patients with unilateral or bilateral renal artery stenosis or stenosis to a solitary kidney since blood urea and serum creatinine may increase in such patients.
Copalia HCT’s sikkerhedsprofil, som er præsenteret herunder, er baseret på kliniske afprøvninger udført med Copalia HCT og de kendte sikkerhedsprofiler af de individuelle komponenter amlodipin, valsartan og hydrochlorthiazid.
The safety profile of Copalia HCT presented below is based on clinical studies performed with Copalia HCT and the known safety profile of the individual components amlodipine, valsartan and hydrochlorothiazide.
Copalia må ikke anvendes til patienter, der er overfølsomme (allergiske) over for amlodipin eller andre lægemidler i gruppen af "dihydropyridinderivater", valsartan eller andre af indholdsstofferne.
Copalia must not be used in patients who are hypersensitive (allergic) to amlodipine or other medicines in the ‘dihydropyridine derivatives’ class, to valsartan, or to any of the other ingredients.
Copalia og ældre patienter (65 år og derover)
Copalia and older people (age 65 years or over)
Copalias sikkerhed og virkning hos børn under 18 år er ikke klarlagt.
The safety and efficacy of Copalia in children aged below 18 years have not been established.
Copolímero de metacrilato butilado básico
Silicified microcrystalline cellulose Basic butylated methacrylate copolymer
Copovidon (nominel K-værdi 28) Kolloid vandfri silica Magnesiumstearat
Copovidone (K-value nominally 28) Colloidal anhydrous silica Magnesium stearate